Targeting the Isoprenoid Pathway to Abrogate Progression of Pulmonary Fibrosis

Free Radical Biology and Medicine - Netherlands
doi 10.1016/j.freeradbiomed.2015.04.031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Targeting NOX Enzymes in Pulmonary Fibrosis

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2012English

Sorghum Isoprenoid Pathway Responses to Manganese Concentration

Canadian Journal of Plant Science
HorticulturePlant ScienceAgronomyCrop Science
1991English

Targeting the PI3K/Akt/mTOR Signalling Pathway in Cystic Fibrosis

Scientific Reports
Multidisciplinary
2017English

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs
Cancer ResearchToxicologyOncologyPharmaceuticsPharmacology
2016English

Blockade of the WNT/Β-Catenin Pathway Attenuates Bleomycin-Induced Pulmonary Fibrosis

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Targeting the MRTF/SRF Gene Transcription Pathway in Conjunctival Fibrosis in Glaucoma

The Lancet
Medicine
2016English

Noninvasive Imaging of Tumor Progression, Metastasis, and Fibrosis Using a Nanobody Targeting the Extracellular Matrix

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Targeting Factor D of the Alternative Complement Pathway Reduces Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration

Science Translational Medicine
Medicine
2017English

Chemical Approaches to Inhibitors of Isoprenoid Biosynthesis: Targeting Farnesyl and Geranylgeranyl Pyrophosphate Synthases

RSC Advances
ChemistryChemical Engineering
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy